Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 1
2005 3
2006 2
2007 2
2011 2
2012 1
2013 4
2014 2
2015 2
2016 2
2018 1
2020 2
2021 1
2022 1
2023 2
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Zeiser R, et al. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122. N Engl J Med. 2021. PMID: 34260836 Clinical Trial.
Epigenetic regulation of T cell lineages in skin and blood following hematopoietic stem cell transplantation.
Pandey RV, Strobl J, Redl A, Unterluggauer L, Gail L, Kleissl L, Müller S, Atzmüller D, Fife-Gernedl V, Krausgruber T, Knaus H, Mitterbauer M, Wohlfarth P, Rabitsch W, Bock C, Stary G. Pandey RV, et al. Among authors: mitterbauer m. Clin Immunol. 2023 Mar;248:109245. doi: 10.1016/j.clim.2023.109245. Epub 2023 Jan 23. Clin Immunol. 2023. PMID: 36702179 Free article.
Anti-Apoptotic Molecule BCL2 Is a Therapeutic Target in Steroid-Refractory Graft-Versus-Host Disease.
Strobl J, Pandey RV, Krausgruber T, Kleissl L, Reininger B, Herac M, Bayer N, Krall C, Wohlfarth P, Mitterbauer M, Kalhs P, Rabitsch W, Bock C, Hopfinger G, Stary G. Strobl J, et al. Among authors: mitterbauer m. J Invest Dermatol. 2020 Nov;140(11):2188-2198. doi: 10.1016/j.jid.2020.02.029. Epub 2020 Apr 2. J Invest Dermatol. 2020. PMID: 32247860 Free article.
Emergency Department Utilization Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Longitudinal Analysis of 557 Patients.
Cserna J, Baumann CK, Lobmeyr E, Grafeneder J, Ettl F, Eibensteiner F, Rabitsch W, Mitterbauer M, Knaus HA, Wohlfarth P. Cserna J, et al. Among authors: mitterbauer m. Transplant Cell Ther. 2023 May;29(5):321.e1-321.e9. doi: 10.1016/j.jtct.2023.02.018. Epub 2023 Feb 24. Transplant Cell Ther. 2023. PMID: 36842484 Free article.
CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
Greinix HT, Kuzmina Z, Weigl R, Körmoczi U, Rottal A, Wolff D, Kralj M, Kalhs P, Mitterbauer M, Rabitsch W, Edinger M, Holler E, Pickl WF. Greinix HT, et al. Among authors: mitterbauer m. Biol Blood Marrow Transplant. 2015 Feb;21(2):250-8. doi: 10.1016/j.bbmt.2014.11.010. Epub 2014 Nov 20. Biol Blood Marrow Transplant. 2015. PMID: 25460358 Free article. Clinical Trial.
Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
Vogl UM, Nagayama K, Bojic M, Hoda MA, Klepetko W, Jaksch P, Dekan S, Siersch V, Mitterbauer M, Schellongowski P, Greinix HT, Petkov V, Schulenburg A, Kalhs P, Rabitsch W. Vogl UM, et al. Among authors: mitterbauer m. Transplantation. 2013 Feb 27;95(4):623-8. doi: 10.1097/TP.0b013e318277e29e. Transplantation. 2013. PMID: 23274967
33 results